US firm Meredith-Springfield has acquired latest injection stretch-blow molding machine (ISBM) technology from Japan’s Aoki Technical Laboratory. The move will allow Meredith-Springfield to economically manufacture a new product ...
Tags: blow molding machine, beverages
Rainbow Coral and its joint venture partner, Therakine, have reached a major new milestone in the development of a revolutionary new drug delivery technology. The companies reached terms to initiate Phase II of research and analysis on a ...
Tags: RBCC, Drug Delivery Development
A.P. Pharma, a specialty pharmaceutical company, has initiated a program to expand its pipeline of sustained release products, including a new program targeting the relief of post-surgical pain. The company also announced it will pursue a ...
Tags: A.P.Pharma, Pipeline Expansion
International Paint announced that its two latest hull-coating technologies have already made a significant impact on the market within months of their launch in March. Designed to address the industry issues of predictability in ...
Huntsman Textile Effects (HTE), Singapore, has introduced the PHOBOL? CP range of fluoropolymer textile finishes offering dual-action stain management for apparel. The new range, which includes Phobol CP-DP and CP-DL, combines an oil- and ...
The US Food and Drug Administration (FDA) has accepted Neos Therapeutics' new drug application (NDA) 505(b)(2) filing for NT0202, an extended release (XR) orally disintegrating tablet (ODT) formulation of Amphetamine Polistirex. The ...
New analysis from Frost & Sullivan, Strategic Analysis of the Global Market for Marine Coatings, finds that the market earned revenues of $5,030.1 million in 2011 and estimates this to reach $10,216.3 million in 2018. The research covers ...
Tags: Frost&Sullivan, Marine Coatings, coatings
Catalent has started supplying its antipsychotic drug, Abilify, an orally disintegrating tablet (ODT) to Otsuka Pharmaceutical. Abilify ODT, which utilizes Catalent's Zydis fast dissolve drug delivery technology, is designed to improve ...
Tags: Catalent, Abilify Antipsychotic Drug, Otsuka Pharma, antipsychotic drug
Wockhardt, a pharmaceutical and biotechnology company, has received final FDA approval for marketing 100mg, 150mg and 200mg 12 hour extended release tablets of Bupropion HCl indicated for depression. Wockhardt has announced the immediate ...